Report

Riding the Wave of Healing and Grow with Purpose

Report
Riding the Wave of Healing and Grow with Purpose


In recent years, the China pharmaceutical and healthcare industry has evolved under the influence of three key factors: policy pressures, market dynamics, and shifting consumer perceptions. At this crossroads of “new challenges” and “new opportunities,” Xiaohongshu, in collaboration with NielsenIQ, recently released the Riding the Wave of Healing, Growing with Purpose: 2025-2026 Consumer Trends White Paper for the Pharmaceutical and Health Industry (hereinafter referred to as the “White Paper”). Focusing on the core variable—”people”—it delves into the evolving perceptions, behavioral trends, consumption pathways, and motivations of health-conscious consumers, aiming to help brands gain insights into the current landscape and future direction of the pharmaceutical industry.

Cindy Yang, Vice President and Head of Digital Platform Strategic Partnerships at NielsenIQ China, remarked: “Health is no longer just a physical state but an active lifestyle choice and a form of value expression. This White Paper, anchored in human sentiment, reconstructs industry logic from a researcher’s perspective, revealing how emotional value and cognitive evolution jointly drive the market and shape a new growth paradigm.”


The Leap in Consumer Perception: From ‘No Illness Means Wellness’ to ‘Proactive Management’

The definition of health is being rewritten by consumers. In the past, health was understood as the “absence of disease,” but today, it is a multi-layered, multi-dimensional state—a systemic concept encompassing physical, mental, emotional, and social well-being. According to the White Paper, respondents in the pharmaceutical and health sector selected an average of five descriptors to define “health,” with good sleep quality/regular routines, a positive mindset, and strong immunity/less susceptibility to illness ranking as the top three. Health is no longer about “how to avoid sickness” but about “how to live better.”

This shift in perception has led to an upgrade in demand—health is transitioning from “medical consumption” to an “investment in lifestyle.” Coupled with the influence of China’s “Healthy China 2030” strategy and the trend of younger populations facing health issues, health expenditures are becoming more rigid. The White Paper notes that in 2023, China’s macro health expenditure reached 9.06 trillion yuan, with per capita healthcare spending hitting 2,460 yuan, accounting for 9.2% of total expenditures.


Health Consumption Motivation: Starting with Function, Ending with Meaning

With cognition as the starting point, consumers’ motivations for health spending are also evolving. In an era of accelerating social rhythms and mounting pressures, health has transformed from a physiological concern into a psychological and social issue. Drivers include internal factors like peace of mind and symptom relief and external factors like convenience and social recognition.

The White Paper categorizes these drivers into four key motivations:

  • Functional Motivation (“Treatment, Prevention, Maintenance”)
  • Efficiency Motivation (“Reducing Worry, Gaining Certainty”)
  • Social Motivation (“Identity Expression and Group Belonging”)
  • Meaning Motivation (“Enhancing Quality of Life”)

These motivations ripple outward, encompassing not only basic functional needs but also psychological comfort, social validation, and aspirations for the future—ultimately shaping the true drivers of consumption behavior.


The Health Consumption Landscape: Segmented Audiences and Shifting Scenarios

The interplay of consumer cognition and motivation paints a complex picture of the pharmaceutical and health industry. The White Paper highlights that payers in healthcare are undergoing a transition. Changing perceptions of health consumption and shifts in social structures are transforming the demographic profile of health spenders—from a rigid, elderly-dominated expenditure to a diverse and stratified consumption landscape.

Using the framework of “Label × Scenario × Motivation,” the White Paper identifies eight key consumer segments in pharmaceutical and health:

Diverse consumer segments are redrawing the map of health purchasing pathways. Single channels can no longer accommodate new health paradigms—social media has emerged as the primary touchpoint, shaping pre-purchase awareness and decisions. The White Paper reveals:

  • 47%+ of 18–25-year-olds first learn about health products via social media.
  • Xiaohongshu’s health-related笔记 (notes) grew 100%+ YoY.
  • The new consumer journey: Awareness & Decision (Social Media) → Purchase (E-commerce/Pharmacies).

The Amplifier Effect of Social Media

Content as the Catalyst for Awareness

With the consumer journey now front-loaded, brands must compete for minds on social platforms before users enter pharmacies or open shopping apps. Xiaohongshu’s unique value lies in connecting three critical elements:

  1. People Its users aren’t passive audiences but主动搜索 (active seekers), expressers, and validators. Their needs aren’t manufactured—they’re understood and illuminated.
  2. Scenarios Health decisions don’t happen in hospitals but in life’s margins: during sleepless nights, skincare routines, or日常 (daily) self-care moments. Xiaohongshu’s ecosystem turns these fragments into brand-user connections.
  3. Motivations Traditional health messaging stuck to “efficacy” and “relief.” Xiaohongshu reframes it as “how to live better”—translating功能点 (features) into tangible benefits like “I feel safer,” “I’ve regained control,” or “I’m more stable.”

Ultimately, Xiaohongshu elevates brands from “trusted” to “beloved” by fostering emotional resonance. When users voluntarily share their stories, the brand’s value takes root organically.